Mitigating DKA in Type 1 Diabetes for Safe Use of SGLT Inhibitors Using Dual Continuous Ketone and Glucose Monitoring.

Clinical trial NCT07325201 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07325201
Sponsor: HealthPartners Institute
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus Chronic Kidney Disease (CKD) With Diabetes Mellitus (DM)Chronic Kidney Disease Diabetic Ketoacidosis Ketones

Start date: 2026-09-01
Primary completion: 2028-05-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.